# Pre- Vs Postoperative Thromboprophylaxis for Liver Resection

Study · id `cardio:ct-nct04731558` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04731558](<https://clinicaltrials.gov/study/NCT04731558>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04731558

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1012 participants.

## Technical summary

Registry record NCT04731558. Randomized; triple masking; primary purpose prevention. Start 2021-02-10 (actual); primary completion 2027-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 1012 participants (planned count; ClinicalTrials.gov record NCT04731558, source copy `cardio:ctgov-nct04731558-2025-02-14`, retrieved 2026-10-31)
- Started: 2021-02-10 (actual) (ClinicalTrials.gov record NCT04731558, source copy `cardio:ctgov-nct04731558-2025-02-14`, retrieved 2026-10-31)
- Primary completion: 2027-02 (anticipated) (ClinicalTrials.gov record NCT04731558, source copy `cardio:ctgov-nct04731558-2025-02-14`, retrieved 2026-10-31)
- Completion: 2027-03 (anticipated) (ClinicalTrials.gov record NCT04731558, source copy `cardio:ctgov-nct04731558-2025-02-14`, retrieved 2026-10-31)
- Countries: Finland; Norway (ClinicalTrials.gov record NCT04731558, source copy `cardio:ctgov-nct04731558-2025-02-14`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04731558-2025-02-14`, retrieved 2026-10-31)

## The registry's words

- Brief title: Pre- Vs Postoperative Thromboprophylaxis for Liver Resection
- Acronym: PREPOSTEROUS
- Condition: Liver Cancer
- Condition: Surgery
- Condition: Thrombosis, Deep Vein
- Condition: Embolism, Pulmonary
- Condition: Bleeding
- Intervention (Drug): enoxaparin or tinzaparin or dalteparin
- Intervention (Drug): No intervention
- Lead sponsor: Helsinki University Central Hospital
- Lead sponsor class: OTHER
- Collaborator: Academy of Finland
- Collaborator class: OTHER
- Collaborator: The Finnish Medical Association
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: Helsinki University Central Hospital (`cardio:org-helsinki-university-central-hospital`)

## Provenance

Content hash: 9a06b0dc6b6f015808e0d48abf0feca83a25c24b821ba21e4b2db4fb9f0f191b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
